NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
MondayMar 13, 2017 7:30 pm

ARI Network Services, Inc. (NASDAQ: ARIS) Starts Presentation at 29th Annual ROTH Conference

ARI Network Services (NASDAQ: ARIS) (“ARI”) offers a suite of SaaS, software tools, and marketing services to help dealers, equipment manufacturers and distributors in selected vertical markets Sell More Stuff!™ -- online and in-store. The company’s innovative products are powered by a proprietary data repository of enriched original equipment and aftermarket electronic content spanning more than 17 million active part and accessory SKUs and 750,000 equipment models. ARI removes the complexity of selling and servicing new and used vehicle inventory, parts, garments and accessories for customers in the automotive tire and wheel aftermarket, power-sports, outdoor power equipment, marine, home medical…

Continue Reading

MondayMar 13, 2017 7:30 pm

Castle Brands, Inc. (NYSE: ROX) Starts Presentation at 29th Annual ROTH Conference

Castle Brands (NYSE: ROX) develops, markets, imports, and sells beverage alcohol products in the United States and internationally. Its product categories include rum, whiskey, liqueurs, vodka, tequila, wine, and other spirits, as well as ginger beer and ready-to-drink cocktails. The company offers its products under the Jefferson's®, Goslings® Rums, Knappogue Castle Whiskey®, Clontarf® Irish Whiskey, Pallini® Limoncello, Boru® Vodka, Brady's® Irish Cream, The Arran Malt® Single Malt Scotch Whisky, The Robert Burns Scotch Whisky and Machrie Moor Scotch Whisky brands through a network of wholesale distributors and state-operated agencies. Castle Brands was incorporated in 2009 and is based in New York, New York. For more information,…

Continue Reading

MondayMar 13, 2017 7:30 pm

Agile Therapeutics, Inc. (NASDAQ: AGRX) Starts Presentation at 29th Annual ROTH Conference

Agile Therapeutics (NASDAQ: AGRX) is a specialty pharmaceutical company that focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate, Twirla, is a once-weekly contraceptive patch currently in phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. For more information, visit…

Continue Reading

MondayMar 13, 2017 7:30 pm

Connection, Inc. (NASDAQ: CNXN) Starts Presentation at 29th Annual ROTH Conference

Connection (NASDAQ: CNXN), is the combined corporate brand name for PC Connection, Inc. along with its subsidiaries PC Connection Sales, GovConnection, and MoreDirect. Headquartered in Merrimack, NH with offices throughout the United States, the company continues to deliver custom-configured computer systems overnight from its certified technical configuration lab at its distribution center in Wilmington, OH. In addition, the company has over 2,500 technical certifications that permits it to solve the most complex issue. Connections also services international customers through its GlobalServe subsidiary, a global IT procurement and service management company. For more information, visit the company’s website www.connection.com. About NetworkNewsWire…

Continue Reading

MondayMar 13, 2017 7:30 pm

Charles & Colvard Ltd. (NASDAQ: CTHR) Starts Presentation at 29th Annual ROTH Conference

Charles & Colvard (NASDAQ: CTHR) is the original creator of Forever Classic™, Forever Brilliant® and Forever One™ moissanite gemstones for fine jewelry. Moissanite is unique, available in three color grades (colorless, near-colorless and faint color) and produced from silicon carbide (SiC) crystals. Charles & Colvard Created Moissanite® is sold with a Certificate of Authenticity and Limited Lifetime Warranty to wholesale distributors, manufacturers, retailers, TV shopping networks and designers as loose stones or set in a wide variety of quality metal setting options. Charles & Colvard, Ltd. also sells direct to consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, and…

Continue Reading

MondayMar 13, 2017 7:30 pm

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) Starts Presentation at 29th Annual Roth Conference

Syndax Pharmaceuticals (NASDAQ: SNDX) is a late-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics in oncology. The company’s lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. For more information, visit the company’s website at www.syndax.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

MondayMar 13, 2017 7:30 pm

Inotek Pharmaceuticals Corp. (NASDAQ: ITEK) Starts Presentation at 29th Annual ROTH Conference

Inotek Pharmaceuticals (NASDAQ: ITEK) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases. The company’s lead product candidate, trabodenoson, is a selective adenosine mimetic currently in phase 3 development. Trabodenoson was developed in Inotek’s laboratories and is designed to restore the eye’s natural pressure control mechanism. Additionally, the company is evaluating the potential for selective adenosine mimetics to address optic neuropathies and other degenerative retinal diseases. For more information, visit the company’s website at www.inotekpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

Continue Reading

MondayMar 13, 2017 7:00 pm

Revolution Lighting Technologies, Inc. (NASDAQ: RVLT) Starts Presentation at 29th Annual Roth Conference

Revolution Lighting Technologies (NASDAQ: RVLT) designs, manufactures, markets and sells light emitting diode (LED) lighting solutions focusing on the industrial, commercial and government markets in the United States, Canada and internationally. It markets a line of high-quality interior and exterior LED lamps and fixtures under the Seesmart brand. The company also supplies LED illumination for the signage industry, manufactures outdoor LED products, and offers a patented and licensed monitoring and smart grid control system for outdoor lighting applications. For more information, visit the company’s website at www. rvlti.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

MondayMar 13, 2017 7:00 pm

The Joint Corp. (NASDAQ: JYNT) Starts Presentation at 29th Annual Roth Conference

The Joint (NASDAQ: JYNT) develops, owns, operates, franchises, supports and manages chiropractic clinics in the United States. The Joint is reinventing chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. Its membership plans and packages eliminate the need for insurance, and our no-appointment policy, convenient hours and locations make care more accessible. As of July 20, 2016, it operated and franchised approximately 340 clinics. The company was founded in 2010 and is headquartered in Scottsdale, Arizona. For more information, visit the company’s website at www.thejoint.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

Continue Reading

MondayMar 13, 2017 7:00 pm

Verastem, Inc. (NASDAQ: VSTM) Starts Presentation at 29th Annual Roth Conference

Verastem (NASDAQ: VSTM) is a biopharmaceutical company that focuses on discovering and developing drugs targeting cancer stem cells (CSCs). Its programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. The company’s product candidate FAK inhibitor, VS-6063, is in phase I study in combination with PD-1 inhibitor pembrolizumab and gemcitabine for pancreatic cancer; a phase Ib clinical trial in combination with paclitaxel for patients with ovarian cancer; a phase II study in patients with non-small cell lung cancer; a phase II trial preceding surgery in mesothelioma; and a phase I/Ib clinical trial in combination with avelumab in patients…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers